Brain-Computer Interface

The Brain-Computer Interface (BCI) concept covers technologies that directly measure and modulate neural activity to enable communication and control between the brain and external devices. Core tracks include non‑invasive and implantable neural sensing hardware (EEG/ECoG/microelectrodes), neuromodulation systems, low‑latency signal processing and AI decoding software, neuroprosthetics and assistive communication, AR/VR and robotics integration, biocompatible materials and power, as well as safety, data, and clinical translation platforms.The sector's total market cap is 8484.22 billion USD, with a 24h change of -2.07%. Among 9 constituents, 4 are up (44.44%) and 5 are down (55.56%). The top gainer is Abbott Laboratories (ABT), with a 24h increase of +10.67%.Leadership strength contrasts with uneven breadth, signaling selective risk-on. Trade top innovators on pullbacks; build core stakes around earnings windows and the evolving rate path.